SALLAKI MR TABLET 10'S

Sallaki MR Tablet 10's is a medication used to relieve pain and inflammation associated with osteoarthritis and joint pain.

The main ingredient in Sallaki MR Tablet 10's is Boswellia serrata extract.

Take Sallaki MR Tablet 10's as directed by your doctor. Generally, it is taken with water after a meal.

Common side effects of Sallaki MR Tablet 10's may include stomach pain, diarrhea, and nausea.

It is important to consult a doctor before using Sallaki MR Tablet 10's during pregnancy.

Sallaki MR Tablet 10's is usually recommended to be taken after a meal to avoid stomach upset.

Store Sallaki MR Tablet 10's at room temperature, away from direct sunlight and moisture.

Sallaki MR Tablet 10's can interfere with other medications. Therefore, consult your doctor before starting any new medication.

Sallaki MR Tablet 10's is not primarily a painkiller, but it can provide pain relief by reducing inflammation.

Alternatives to Sallaki MR Tablet 10's may include other Boswellia serrata-containing medications and other pain relief drugs.

The dosage of Sallaki MR Tablet 10's is determined by the doctor. The usual dosage is one tablet twice a day.

Sallaki MR Tablet 10's is used to treat osteoarthritis, joint pain, and inflammation.

Sallaki MR Tablet 10's does not usually cause drowsiness, but consult a doctor if you experience dizziness or fatigue.

Long-term use of Sallaki MR Tablet 10's may be safe, but it should only be used as advised by a doctor.

Sallaki MR Tablet 10's works by reducing inflammation in the body, thereby providing relief from joint pain and swelling.

Sallaki tablets are primarily used as an adjunct treatment for joint and musculoskeletal conditions associated with pain and inflammation. They are commonly recommended in osteoarthritis, rheumatoid arthritis, spondyloarthropathies, and chronic low back or neck pain to help reduce pain, swelling, and stiffness. Some practitioners also use them in other inflammatory conditions, but these uses may have less robust clinical evidence and should be guided by a healthcare professional.

Sallaki tablets usually contain Boswellia serrata extract, which has anti‑inflammatory properties. Boswellic acids, the active constituents, are thought to inhibit 5‑lipoxygenase and reduce leukotriene production, thereby decreasing inflammatory signaling. They may also modulate other inflammatory mediators and protect cartilage to some extent. This mechanism is different from that of NSAIDs, and Sallaki is often used as a complementary rather than a replacement therapy.

Sallaki tablets do not cure arthritis. Osteoarthritis and most inflammatory arthritides are chronic conditions that require long‑term management. Sallaki may help relieve symptoms such as pain and stiffness and may improve function when used alongside standard therapies, exercise, and lifestyle measures. Disease‑modifying drugs, physical therapy, and weight management remain central to long‑term arthritis care, and treatment decisions should be made with a rheumatologist or treating physician.

The onset of benefit with Sallaki tablets is usually gradual. Some individuals may notice mild improvement in pain or stiffness within 1–2 weeks, but more consistent effects often require several weeks of regular use. Because response varies between patients and products, ongoing assessment by a healthcare professional is important. If there is no meaningful improvement after an adequate trial period, the treatment plan may need to be reassessed.

Available data suggest that Boswellia‑based products are generally well tolerated when used at recommended doses for several weeks to a few months. However, high‑quality long‑term safety data are limited, and different brands may have different extract strengths and excipients. Long‑term use should be supervised by a healthcare professional, especially in people with chronic illnesses, those taking multiple medications, or those with a history of gastrointestinal, liver, or kidney problems.

Commonly reported side effects include mild gastrointestinal symptoms such as nausea, abdominal discomfort, acid reflux, or loose stools. Some people may experience headache or a feeling of fullness. Skin rash, itching, or other allergic manifestations can occur in susceptible individuals. Severe reactions are uncommon but possible. If a patient develops persistent stomach pain, severe diarrhea, breathing difficulty, facial swelling, or widespread rash, they should stop the tablets and seek medical attention promptly.

Sallaki tablets are often used in combination with conventional painkillers such as paracetamol or NSAIDs, and with disease‑modifying antirheumatic drugs in inflammatory arthritis. However, potential interactions can vary depending on the exact formulation and the patient’s overall regimen. Because Boswellia may influence inflammatory pathways and, in theory, drug metabolism, any combination should be reviewed by a doctor or pharmacist, particularly if you are on anticoagulants, immunosuppressants, or multiple chronic medications.

Sallaki tablets are not specifically contraindicated in diabetes or hypertension, but patients with these conditions often take several medications and may have altered organ function. While Boswellia has not been consistently shown to worsen blood glucose or blood pressure, individual responses can vary. People with diabetes or high blood pressure should consult their treating physician before starting Sallaki, monitor their usual parameters regularly, and report any unexpected changes.

Safety and efficacy data for Boswellia‑containing tablets in children and adolescents are limited. Most available studies and product information focus on adults. Use in individuals under 18 years should be considered only under direct medical supervision, after careful assessment of potential benefits and risks, and with attention to age‑appropriate dosing as specified by the prescribing clinician and the product label.

If you miss a dose of Sallaki tablets, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one, as this may increase the risk of side effects without providing additional benefit. If you frequently forget doses, discuss adherence strategies with your healthcare provider.

Sallaki tablets should generally be avoided by individuals with a known allergy or hypersensitivity to Boswellia serrata, frankincense‑related products, or any excipients in the specific brand. Caution or avoidance is also advised in people with significant liver or kidney impairment, those with a history of severe gastrointestinal disease, pregnant or breastfeeding women unless specifically advised by a doctor, and patients taking medicines with a narrow therapeutic index where potential interactions could be clinically important.